(Q36577503)

15 August 2017

1 reference

title

Therapy Insight: managing cardiovascular risk in patients with rheumatoid arthritis (English)

1 reference

15 August 2017

1 reference

3

Roger S Blumenthal

1 reference

15 August 2017

2

Wendy Post

1 reference

15 August 2017

Jon T Giles

1

1 reference

15 August 2017

Joan M Bathon

series ordinal

4

1 reference

15 August 2017

publication date

1 June 2006

1 reference

Nature Clinical Practice Rheumatology

15 August 2017

published in

1 reference

15 August 2017

volume

2

1 reference

15 August 2017

issue

6

1 reference

15 August 2017

page(s)

320-329

1 reference

A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

Case reports of heart failure after therapy with a tumor necrosis factor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

The mortality of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

The risk of congestive heart failure in rheumatoid arthritis: A population-based study over 46 years

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Clinical Images: Hip joint remodeling in systemic-onset juvenile rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Lower limb arterial incompressibility and obstruction in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque: role of activated macrophages and inflammatory cytokines

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Expression of proinflammatory cytokines in the failing human heart: comparison of recent-onset and end-stage congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Circulating tumour necrosis factor alpha and soluble tumour necrosis factor receptors in patients with different patterns of rheumatoid synovitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Cardiovascular death in rheumatoid arthritis: a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Association of mortality with disease severity in rheumatoid arthritis, independent of comorbidity

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Cardiovascular risk factors in women with and without rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Body composition in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Physical activity, physical fitness, and general health perception among individuals with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Cardiovascular care and cancer screening in female nurses with and without rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Glucocorticoid action and the clinical features of Cushing's syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Endothelial dysfunction in young patients with long-term rheumatoid arthritis and low disease activity

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Clinical trials update: RENEWAL (RENAISSANCE and RECOVER) and ATTACH

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Safety of exercise in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Physiologic changes after diet combined with structured aerobic exercise or lifestyle activity

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Comprehensive coronary risk determination in primary prevention: an imaging and clinical based definition combining computed tomographic coronary artery calcium score and national cholesterol education program risk score

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0178

7 January 2021

Identifiers

DOI

10.1038/NCPRHEUM0178

1 reference

15 August 2017

1 reference